Trial Profile
A Phase 2 Trial of ALIMTA in Pretreated Patients With Unresectable or Metastatic Cancer of the Pancreas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2009
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 03 Jun 2009 New trial record.